Wednesday, August 15, 2018
Congress recently passed, and President Trump signed, the “Right to Try” bill that gives dying patients limited access to drugs that have not yet been approved by the U.S. Food and Drug Administration (FDA). Our Founders would be astonished that...
Researchers have shown for the first time that a form of artificial intelligence or machine learning known as a deep learning convolutional neural network (CNN or ConvNet), is better than experienced dermatologists at detecting skin cancer. Artificial neural network CNNs or...
A new type of personalized cancer vaccine has yielded promising results in an initial clinical trial conducted at the Perelman School of Medicine at the University of Pennsylvania and the Abramson Cancer Center of the University of Pennsylvania. With about...

Related articles